|
1
|
Finck BN and Kelly DP: PGC-1 coactivators:
Inducible regulators of energy metabolism in health and disease. J
Clin Invest. 116:615–622. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Knutti D and Kralli A: PGC-1, a versatile
coactivator. Trends Endocrinol Metab. 12:360–365. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scarpulla RC: Metabolic control of
mitochondrial biogenesis through the PGC-1 family regulatory
network. Biochim Biophys Acta. 1813:1269–1278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Puigserver P and Spiegelman BM: Peroxisome
proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1
alpha): Transcriptional coactivator and metabolic regulator. Endocr
Rev. 24:78–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin J, Handschin C and Spiegelman BM:
Metabolic control through the PGC-1 family of transcription
coactivators. Cell Metab. 1:361–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tritos NA, Mastaitis JW, Kokkotou EG,
Puigserver P, Spiegelman BM and Maratos-Flier E: Characterization
of the peroxisome proliferator activated receptor coactivator 1
alpha (PGC 1alpha) expression in the murine brain. Brain Res.
961:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cowell RM, Blake KR and Russell JW:
Localization of the transcriptional coactivator PGC-1alpha to
GABAergic neurons during maturation of the rat brain. J Comp
Neurol. 502:1–18. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
St-Pierre J, Drori S, Uldry M, Silvaggi
JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al:
Suppression of reactive oxygen species and neurodegeneration by the
PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watkins G, Douglas-Jones A, Mansel RE and
Jiang WG: The localisation and reduction of nuclear staining of
PPARgamma and PGC-1 in human breast cancer. Oncol Rep. 12:483–488.
2004.PubMed/NCBI
|
|
10
|
Feilchenfeldt J, Brüundler MA, Soravia C,
Tötsch M and Meier CA: Peroxisome proliferator-activated receptors
(PPARs) and associated transcription factors in colon cancer:
Reduced expression of PPARgamma-coactivator 1 (PGC-1). Cancer lett.
203:25–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang WG, Douglas-Jones A and Mansel RE:
Expression of peroxisome-proliferator activated receptor-gamma
(PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast
cancer correlates with clinical outcomes. Int J Cancer.
106:752–757. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao
S, Hao J, Yu Z, Zhang J, Zen K, et al: PGC-1alpha induces apoptosis
in human epithelial ovarian cancer cells through a
PPARgamma-dependent pathway. Cell Res. 17:363–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heiden MG Vander, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vazquez F, Lim JH, Chim H, Bhalla K,
Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM
and Puigserver P: PGC1α expression defines a subset of human
melanoma tumors with increased mitochondrial capacity and
resistance to oxidative stress. Cancer cell. 23:287–301. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Plate KH and Risau W: Angiogenesis in
malignant gliomas. Glia. 15:339–347. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee YS, Kang JW, Lee YH and Kim DW: ID4
mediates proliferation of astrocytes after excitotoxic damage in
the mouse hippocampus. Anat Cell Biol. 44:128–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yi MH, Kim S, Zhang E, Kang JW, Park JB,
Lee YH, Chung CK, Kim YM and Kim DW: IQGAP1 expression in spared
CA1 neurons after an excitotoxic lesion in the mouse hippocampus.
Cell Mol Neurobiol. 33:1003–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Golub TR, Slonim DK, Tamayo P, Huard C,
Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri
MA, et al: Molecular classification of cancer: Class discovery and
class prediction by gene expression monitoring. Science.
286:531–537. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vlasblom J, Zuberi K, Rodriguez H, Arnold
R, Gagarinova A, Deineko V, Kumar A, Leung E, Rizzolo K, Samanfar
B, et al: Novel function discovery with GeneMANIA: A new integrated
resource for gene function prediction in Escherichia coli.
Bioinformatics. 31:306–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng H, Liang HL and Wong-Riley M:
Quantitative immuno-electron microscopic analysis of
depolarization-induced expression of PGC-1alpha in cultured rat
visual cortical neurons. Brain Res. 1175:10–16. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deighton RF, Le Bihan T, Martin SF, Gerth
AM, McCulloch M, Edgar JM, Kerr LE, Whittle IR and McCulloch J:
Interactions among mitochondrial proteins altered in glioblastoma.
J Neurooncol. 118:247–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soyal SM, Felder TK, Auer S, Hahne P,
Oberkofler H, Witting A, Paulmichl M, Landwehrmeyer GB, Weydt P and
Patsch W; European Huntington Disease Network, : A greatly extended
PPARGC1A genomic locus encodes several new brain-specific isoforms
and influences Huntington disease age of onset. Hum Mol Genet.
21:3461–3473. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi J, Batchu VV, Schubert M, Castellani
RJ and Russell JW: A novel PGC-1α isoform in brain localizes to
mitochondria and associates with PINK1 and VDAC. Biochem Biophys
Res Commun. 435:671–677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chapman EJ and Knowles MA: Necdin: A multi
functional protein with potential tumor suppressor role? Mol
Carcinog. 48:975–981. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujiwara K, Hasegawa K, Ohkumo T, Miyoshi
H, Tseng YH and Yoshikawa K: Necdin controls proliferation of white
adipocyte progenitor cells. PloS One. 7:e309482012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Niinobe M, Koyama K and Yoshikawa K:
Cellular and subcellular localization of necdin in fetal and adult
mouse brain. Dev Neurosci. 22:310–319. 2000. View Article : Google Scholar : PubMed/NCBI
|
